Literature DB >> 19585162

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.

John E Brazier1, Yaling Yang, Aki Tsuchiya, Donna Louise Rowen.   

Abstract

Clinical studies use a wide variety of health status measures to measure health related quality of life, many of which cannot be used in cost-effectiveness analysis using cost per quality adjusted life year (QALY). Mapping is one solution that is gaining popularity as it enables health state utility values to be predicted for use in cost per QALY analysis when no preference-based measure has been included in the study. This paper presents a systematic review of current practice in mapping between non-preference based measures and generic preference-based measures, addressing feasibility and validity, circumstances under which it should be considered and lessons for future mapping studies. This review found 30 studies reporting 119 different models. Performance of the mappings functions in terms of goodness-of-fit and prediction was variable and unable to be generalised across instruments. Where generic measures are not regarded as appropriate for a condition, mapping does not solve this problem. Most testing in the literature occurs at the individual level yet the main purpose of these functions is to predict mean values for subgroups of patients, hence more testing is required.

Entities:  

Mesh:

Year:  2009        PMID: 19585162     DOI: 10.1007/s10198-009-0168-z

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  179 in total

1.  The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.

Authors:  Nick Kontodimopoulos
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

2.  Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.

Authors:  Mark Parker; Alan Haycox; Jane Graves
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Mapping the Oxford hip score onto the EQ-5D utility index.

Authors:  Rafael A Pinedo-Villanueva; David Turner; Andrew Judge; James P Raftery; Nigel K Arden
Journal:  Qual Life Res       Date:  2012-04-22       Impact factor: 4.147

4.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

Review 5.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

6.  Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM).

Authors:  Ifigeneia Mavranezouli; John E Brazier; Tracey A Young; Michael Barkham
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

7.  Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Authors:  Donna Rowen; John Brazier; Tracey Young; Sabine Gaugris; Benjamin M Craig; Madeleine T King; Galina Velikova
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

8.  Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.

Authors:  Evangelos Kalaitzakis; Maria Benito de Valle; Monira Rahman; Björn Lindkvist; Einar Björnsson; Roger Chapman; Nick Kontodimopoulos
Journal:  Qual Life Res       Date:  2015-10-15       Impact factor: 4.147

9.  Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.

Authors:  Thor Gamst-Klaussen; Gang Chen; Admassu N Lamu; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2015-12-21       Impact factor: 4.147

10.  Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.

Authors:  Anne M Rentz; Jonathan W Kowalski; John G Walt; Ron D Hays; John E Brazier; Ren Yu; Paul Lee; Neil Bressler; Dennis A Revicki
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.